Clinical Trials Browser

Phase 2/3 × Busulfan × Plasma cell × Clear all

NCT03385096 2020-02-25

Mel vs BUCY+VP-16 Conditioning Regimen for MM Undergoing Auto-HSCT

Phase 2/3 Unknown

Multiple Myeloma